Measured Wealth Private Client Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4K Hold
113
﹤0.01% 538
2025
Q4
$14.2K Hold
113
﹤0.01% 526
2025
Q3
$16.5K Buy
+113
New +$17.1K ﹤0.01% 504
2019
Q3
Sell
-1,895
Closed -$215K 207
2019
Q2
$215K Sell
1,895
-874
-32% -$91.5K 0.12% 174
2019
Q1
$279K Buy
+2,769
New +$251K 0.17% 133
2018
Q4
Sell
-1,758
Closed -$160K 732
2018
Q3
$160K Buy
+1,758
New +$156K 0.1% 171

Other funds holding ZTS

Measured Wealth Private Client Group's ZTS Position: Q1 2026 in Review

Measured Wealth Private Client Group held its Zoetis (ZTS) position steady in Q1 2026 at 113 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Measured Wealth Private Client Group first reported a position in ZTS in Q3 2018 and has held it in 6 quarters since. The position peaked at $279K in Q1 2019. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Measured Wealth Private Client Group held 113 shares of Zoetis worth $13.4K as of Q1 2026.
  • Measured Wealth Private Client Group left its Zoetis share count unchanged in Q1 2026.
  • Zoetis made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #538 holding.
  • Measured Wealth Private Client Group first reported a position in Zoetis in Q3 2018 and has held it in 6 quarters since.
  • Measured Wealth Private Client Group's Zoetis position peaked at $279K in Q1 2019.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.